The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of 51 essential formulations, including those used for the treatment of cancer, pain, heart conditions and skin problems.
Indian drug price regulator the National Pharmaceutical Pricing Authority (NPPA) has issued notices to several pharmaceutical companies that have marketed combination drugs without complying Drug Price Control Order (DPCO) 2013.